Inspire Medical Systems, Inc. $INSP Stock Position Lifted by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC lifted its stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 218.9% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,588 shares of the company’s stock after purchasing an additional 3,836 shares during the quarter. Campbell & CO Investment Adviser LLC’s holdings in Inspire Medical Systems were worth $725,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of INSP. Quarry LP raised its position in shares of Inspire Medical Systems by 2,127.3% during the 1st quarter. Quarry LP now owns 245 shares of the company’s stock worth $39,000 after buying an additional 234 shares in the last quarter. Banque Transatlantique SA acquired a new position in shares of Inspire Medical Systems during the first quarter valued at approximately $46,000. Smartleaf Asset Management LLC raised its holdings in Inspire Medical Systems by 27.2% during the first quarter. Smartleaf Asset Management LLC now owns 454 shares of the company’s stock worth $71,000 after purchasing an additional 97 shares in the last quarter. Farther Finance Advisors LLC lifted its position in Inspire Medical Systems by 14.6% in the second quarter. Farther Finance Advisors LLC now owns 603 shares of the company’s stock worth $78,000 after purchasing an additional 77 shares during the period. Finally, Archer Investment Corp bought a new position in Inspire Medical Systems during the 1st quarter valued at $96,000. Institutional investors own 94.91% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Stifel Nicolaus set a $100.00 price objective on Inspire Medical Systems in a research note on Friday, October 24th. Leerink Partners dropped their price target on shares of Inspire Medical Systems from $116.00 to $97.00 and set a “market perform” rating on the stock in a research report on Friday, August 15th. Wall Street Zen lowered shares of Inspire Medical Systems from a “buy” rating to a “hold” rating in a research report on Saturday, July 26th. Zacks Research upgraded shares of Inspire Medical Systems from a “strong sell” rating to a “hold” rating in a report on Monday, October 27th. Finally, KeyCorp restated a “sector weight” rating on shares of Inspire Medical Systems in a report on Tuesday, November 4th. Eight analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Inspire Medical Systems has an average rating of “Hold” and an average price target of $133.88.

Insiders Place Their Bets

In related news, CFO Richard Buchholz sold 11,000 shares of the company’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $93.39, for a total transaction of $1,027,290.00. Following the transaction, the chief financial officer directly owned 44,867 shares of the company’s stock, valued at approximately $4,190,129.13. The trade was a 19.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 4.10% of the company’s stock.

Inspire Medical Systems Price Performance

INSP stock opened at $86.47 on Friday. The firm has a market capitalization of $2.51 billion, a P/E ratio of 58.83, a P/E/G ratio of 9.40 and a beta of 1.14. Inspire Medical Systems, Inc. has a 52-week low of $70.77 and a 52-week high of $216.01. The company’s 50 day simple moving average is $79.52 and its 200-day simple moving average is $109.29.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.53. Inspire Medical Systems had a net margin of 5.05% and a return on equity of 9.41%. The firm had revenue of $224.50 million during the quarter, compared to analyst estimates of $220.39 million. During the same quarter last year, the business posted $0.60 EPS. The company’s revenue was up 10.5% on a year-over-year basis. Sell-side analysts predict that Inspire Medical Systems, Inc. will post 2.16 EPS for the current fiscal year.

Inspire Medical Systems declared that its Board of Directors has authorized a share repurchase plan on Monday, August 11th that allows the company to repurchase $200.00 million in outstanding shares. This repurchase authorization allows the company to reacquire up to 8.6% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s board of directors believes its shares are undervalued.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.